184 related articles for article (PubMed ID: 25045085)
41. Changes in aldehyde dehydrogenase-1 expression during neoadjuvant chemotherapy predict outcome in locally advanced breast cancer.
Alamgeer M; Ganju V; Kumar B; Fox J; Hart S; White M; Harris M; Stuckey J; Prodanovic Z; Schneider-Kolsky ME; Watkins DN
Breast Cancer Res; 2014 Apr; 16(2):R44. PubMed ID: 24762066
[TBL] [Abstract][Full Text] [Related]
42. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome.
Wang YC; Yo YT; Lee HY; Liao YP; Chao TK; Su PH; Lai HC
Am J Pathol; 2012 Mar; 180(3):1159-1169. PubMed ID: 22222226
[TBL] [Abstract][Full Text] [Related]
43. [Expression and Clinical Significance of ALDH1 and Twist in Gastric Adenocarcinoma].
Zhao Y; Jin X; Li N; Zhu B; Qian J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jan; 47(1):54-9. PubMed ID: 27062782
[TBL] [Abstract][Full Text] [Related]
44. EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer.
Knudsen ES; Dervishaj O; Kleer CG; Pajak T; Schwartz GF; Witkiewicz AK
Cell Cycle; 2013 Jul; 12(13):2042-50. PubMed ID: 23759596
[TBL] [Abstract][Full Text] [Related]
45. High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma.
Emori M; Tsukahara T; Murase M; Kano M; Murata K; Takahashi A; Kubo T; Asanuma H; Yasuda K; Kochin V; Kaya M; Nagoya S; Nishio J; Iwasaki H; Sonoda T; Hasegawa T; Torigoe T; Wada T; Yamashita T; Sato N
PLoS One; 2013; 8(12):e84187. PubMed ID: 24376795
[TBL] [Abstract][Full Text] [Related]
46. Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.
Yasuda K; Torigoe T; Mariya T; Asano T; Kuroda T; Matsuzaki J; Ikeda K; Yamauchi M; Emori M; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
Lab Invest; 2014 Dec; 94(12):1355-69. PubMed ID: 25329002
[TBL] [Abstract][Full Text] [Related]
47. Identification of biological properties of intralymphatic tumor related to the development of lymph node metastasis in lung adenocarcinoma.
Kirita K; Ishii G; Matsuwaki R; Matsumura Y; Umemura S; Matsumoto S; Yoh K; Niho S; Goto K; Ohmatsu H; Ohe Y; Nagai K; Ochiai A
PLoS One; 2013; 8(12):e83537. PubMed ID: 24376714
[TBL] [Abstract][Full Text] [Related]
48. Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer.
Mieog JS; de Kruijf EM; Bastiaannet E; Kuppen PJ; Sajet A; de Craen AJ; Smit VT; van de Velde CJ; Liefers GJ
BMC Cancer; 2012 Jan; 12():42. PubMed ID: 22280212
[TBL] [Abstract][Full Text] [Related]
49. The ALDH1⁺ subpopulation of the human NMFH-1 cell line exhibits cancer stem-like characteristics.
Li D; Zhang T; Gu W; Li P; Cheng X; Tong T; Wang W
Oncol Rep; 2015 May; 33(5):2291-8. PubMed ID: 25760144
[TBL] [Abstract][Full Text] [Related]
50. ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma.
Zhou JH; Hanna EY; Roberts D; Weber RS; Bell D
Head Neck; 2013 Apr; 35(4):575-8. PubMed ID: 22581680
[TBL] [Abstract][Full Text] [Related]
51. Aldehyde dehydrogenases in early stage lung cancer: nuclear expression.
López-González A; Salas C; Provencio M; Córdoba M; Gamallo C
Clin Transl Oncol; 2014 Oct; 16(10):931-4. PubMed ID: 24643706
[TBL] [Abstract][Full Text] [Related]
52. Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers.
Deng S; Yang X; Lassus H; Liang S; Kaur S; Ye Q; Li C; Wang LP; Roby KF; Orsulic S; Connolly DC; Zhang Y; Montone K; Bützow R; Coukos G; Zhang L
PLoS One; 2010 Apr; 5(4):e10277. PubMed ID: 20422001
[TBL] [Abstract][Full Text] [Related]
53. Aldehyde Dehydrogenase 1 (ALDH1) Promotes the Toxicity of TRAIL in Non-Small Cell Lung Cancer Cells via Post-Transcriptional Regulation of MEK-1 Expression.
Tian S; Liu DH; Wang D; Ren F; Xia P
Cell Physiol Biochem; 2018; 51(1):217-227. PubMed ID: 30448845
[TBL] [Abstract][Full Text] [Related]
54. Multiple differences in agonist and antagonist pharmacology between human and guinea pig histamine H1-receptor.
Seifert R; Wenzel-Seifert K; Burckstummer T; Pertz HH; Schunack W; Dove S; Buschauer A; Elz S
J Pharmacol Exp Ther; 2003 Jun; 305(3):1104-15. PubMed ID: 12626648
[TBL] [Abstract][Full Text] [Related]
55. Effect of ALDH1 on prognosis and chemoresistance by breast cancer subtype.
Kida K; Ishikawa T; Yamada A; Shimada K; Narui K; Sugae S; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
Breast Cancer Res Treat; 2016 Apr; 156(2):261-9. PubMed ID: 26975188
[TBL] [Abstract][Full Text] [Related]
56. All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells.
Young MJ; Wu YH; Chiu WT; Weng TY; Huang YF; Chou CY
Carcinogenesis; 2015 Apr; 36(4):498-507. PubMed ID: 25742746
[TBL] [Abstract][Full Text] [Related]
57. Cross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration.
Alonso N; Fernandez N; Notcovich C; Monczor F; Simaan M; Baldi A; Gutkind JS; Davio C; Shayo C
Mol Pharmacol; 2013 May; 83(5):1087-98. PubMed ID: 23462507
[TBL] [Abstract][Full Text] [Related]
58. ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
Nastały P; Filipska M; Morrissey C; Eltze E; Semjonow A; Brandt B; Pantel K; Bednarz-Knoll N
Transl Res; 2019 Jan; 203():49-56. PubMed ID: 30287243
[TBL] [Abstract][Full Text] [Related]
59. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties.
Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M
J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460
[TBL] [Abstract][Full Text] [Related]
60. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
Deng Y; Zhou J; Fang L; Cai Y; Ke J; Xie X; Huang Y; Huang M; Wang J
Br J Cancer; 2014 Jan; 110(2):430-4. PubMed ID: 24327017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
